Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage <scp>IA</scp> non‐small cell lung cancer-Reference-Cited by-同舟云学术

Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage IA non‐small cell lung cancer

Published:2022-02-11 Issue:7 Volume:13 Page:947-955
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Duan Jin¹,Lv Guoli¹,Zhu Nanye¹,Chen Xin²^ORCID,Shao Yang²³,Liu Yong²,Zhao Wei¹,Shi Yunfei¹

Affiliation:

1. Department of Thoracic Surgery the First Affiliated Hospital of Kunming Medical University Kunming China

2. Geneseeq Research Institute, Nanjing Geneseeq Technology Inc. Nanjing China

3. School of Public Health Nanjing Medical University Nanjing China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14329

Reference48 articles.

1. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients

2. American Cancer SocietyKey Statistics for Lung Cancer 2021. [updated January 12 2021; cited 2021 March 9]. Available from:https://www.cancer.org/cancer/lung-cancer/about/key-statistics.html.

3. Immunotherapy in patients with early stage resectable nonsmall cell lung cancer

4. National Comprehensive Cancer Network.Early and Locally Advanced Non‐Small Cell Lung Cancer 2021[cited 2021 December 20]. Available from:https://www.nccn.org/patients/guidelines/content/PDF/lung-early-stage-patient.pdf.

5. Treating Early‐stage Non‐Small Cell Lung Cancer With Durvalumab and Radiation Therapy.https://ClinicalTrials.gov/show/NCT04716946.n.d.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events?;Cancers;2024-03-22

2. Effects of IFN-γ on the immunological microenvironment and TAM polarity in stage IA non-small cell lung cancer and its mechanisms;BMC Pulmonary Medicine;2024-01-22

3. Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer;Translational Lung Cancer Research;2023-04

4. Expression of PD-L1 through evolution phase from pre-invasive to invasive lung adenocarcinoma;BMC Pulmonary Medicine;2023-01-16

5. Recent Trends in Diagnostic Biomarkers of Tumor Microenvironment;Molecular Imaging and Biology;2022-12-14